19,637 Shares in Humana Inc. $HUM Bought by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. bought a new stake in Humana Inc. (NYSE:HUM) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 19,637 shares of the insurance provider’s stock, valued at approximately $7,637,000.

Several other institutional investors and hedge funds have also bought and sold shares of HUM. Montag A & Associates Inc. grew its stake in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares during the period. Johnson Financial Group Inc. bought a new position in shares of Humana in the 2nd quarter worth approximately $26,000. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana in the fourth quarter worth approximately $27,000. Trust Co. of Vermont purchased a new position in shares of Humana in the second quarter worth approximately $28,000. Finally, Reflection Asset Management bought a new stake in Humana during the fourth quarter valued at approximately $29,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on HUM. Wolfe Research reaffirmed an “outperform” rating and set a $450.00 target price on shares of Humana in a report on Monday, August 24th. Raymond James Financial cut shares of Humana from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 30th. TD Cowen boosted their price objective on shares of Humana from $350.00 to $370.00 and gave the company a “hold” rating in a research report on Friday, July 31st. Piper Sandler upgraded Humana from a “hold” rating to an “overweight” rating and set a $463.00 price objective for the company in a research note on Thursday, July 30th. Finally, William Blair assumed coverage on Humana in a report on Wednesday, May 20th. They issued an “outperform” rating on the stock. Fourteen research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus target price of $403.91.

Humana Price Performance

HUM stock opened at $386.92 on Friday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The company’s fifty day moving average price is $385.60 and its 200-day moving average price is $288.47. Humana Inc. has a one year low of $163.11 and a one year high of $428.88. The company has a market capitalization of $46.46 billion, a PE ratio of 36.61, a price-to-earnings-growth ratio of 2.20 and a beta of 0.72.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. Humana’s revenue for the quarter was up 26.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.27 EPS. On average, equities analysts anticipate that Humana Inc. will post 9.12 EPS for the current fiscal year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.